UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations

Frontiers in immunology, 2018-12, Vol.9, p.2936-2936

2018

Volltextzugriff (PDF)

Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1

Journal of allergy and clinical immunology, 2016-08, Vol.138 (2), p.558-567.e11

2016

Volltextzugriff (PDF)

Alum impairs tolerogenic properties induced by allergoid‐mannan conjugates inhibiting mTOR and metabolic reprogramming in human DCs

Allergy (Copenhagen), 2020-03, Vol.75 (3), p.648-659

2020

Volltextzugriff (PDF)

Trained immunity induction by the inactivated mucosal vaccine MV130 protects against experimental viral respiratory infections

Cell reports (Cambridge), 2022-01, Vol.38 (1), p.110184-110184, Article 110184

2022

Volltextzugriff (PDF)

Grass pollen allergoids conjugated with mannan for subcutaneous and sublingual immunotherapy: a dose-finding study

Frontiers in immunology, 2024-06, Vol.15, p.1431351

2024

Volltextzugriff (PDF)

A pilot study of immunotherapy in dogs with atopic dermatitis using a mannan‐Dermatophagoides farinae allergoid targeting dendritic cells

Veterinary dermatology, 2018-10, Vol.29 (5), p.449-e152

2018

Volltextzugriff (PDF)

The Universal Dynamics of Tumor Growth

Biophysical journal, 2003-11, Vol.85 (5), p.2948-2961

2003

Volltextzugriff (PDF)

Candida albicans V132 induces trained immunity and enhances the responses triggered by the polybacterial vaccine MV140 for genitourinary tract infections

Frontiers in immunology, 2022-11, Vol.13, p.1066383

2022

Volltextzugriff (PDF)

A Combination of Polybacterial MV140 and Candida albicans V132 as a Potential Novel Trained Immunity-Based Vaccine for Genitourinary Tract Infections

Frontiers in immunology, 2021-01, Vol.11, p.612269-612269

2021

Volltextzugriff (PDF)

State of the Art in CAR-T Cell Therapy for Solid Tumors: Is There a Sweeter Future?

Cells (Basel, Switzerland), 2024-05, Vol.13 (9), p.725

2024

Volltextzugriff (PDF)

MV130 in the Prevention of Recurrent Respiratory Tract Infections: A Retrospective Real-World Study in Children and Adults

Vaccines (Basel), 2024-02, Vol.12 (2), p.172

2024

Volltextzugriff (PDF)

MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic E. coli in Experimental Urinary Tract Infection

Vaccines (Basel), 2024-05, Vol.12 (5), p.535

2024

Volltextzugriff (PDF)

Skin Testing With Peach Peel Extract Versus Serum IgE to Pru p 3 as a Stronger Predictor of Peach-Induced Anaphylaxis

Allergy, 2021, Asthma & Immunology Research, 13(6), , pp.922-932

2021

Volltextzugriff (PDF)

Extending the clinical horizons of mucosal bacterial vaccines: current evidence and future prospects

Current drug targets, 2014-01, Vol.15 (12), p.1132-1143

2014

Volltextzugriff (PDF)

Influence of environmental drivers on allergy to pollen grains in a case study in Spain (Madrid): meteorological factors, pollutants, and airborne concentration of aeroallergens

Environmental science and pollution research international, 2021-10, Vol.28 (38), p.53614-53628

2021

Volltextzugriff (PDF)

Human Oral Epithelial Cells Impair Bacteria-Mediated Maturation of Dendritic Cells and Render T Cells Unresponsive to Stimulation

Frontiers in immunology, 2019-06, Vol.10, p.1434-1434

2019

Volltextzugriff (PDF)

Allergoid–mannan conjugates reprogram monocytes into tolerogenic dendritic cells via epigenetic and metabolic rewiring

Journal of allergy and clinical immunology, 2022-01, Vol.149 (1), p.212-222.e9

2022

Volltextzugriff (PDF)

Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Children: A Randomized, Double-Blind, Placebo-controlled Clinical Trial

American journal of respiratory and critical care medicine, 2021-08, Vol.204 (4), p.462-472

2021

Volltextzugriff (PDF)

Do bacterial vaccines/adjuvants prevent wheezing episodes in children?

Current opinion in allergy and clinical immunology, 2022-12, Vol.22 (6), p.380-386

2022

Volltextzugriff (PDF)

A randomized, double‐blind, placebo‐controlled trial with mannan‐conjugated birch pollen allergoids

Allergy (Copenhagen), 2024-04, Vol.79 (4), p.990-1000

2024

Volltextzugriff (PDF)

Allergoid‐mannan conjugates imprint tolerogenic features in human macrophages

Allergy (Copenhagen), 2022-01, Vol.77 (1), p.320-323

2022

Volltextzugriff (PDF)

From trained immunity in allergy to trained immunity‐based allergen vaccines

Clinical and experimental allergy, 2023-02, Vol.53 (2), p.145-155

2023

Volltextzugriff (PDF)

Novel vaccines targeting dendritic cells by coupling allergoids to mannan

Allergo journal international, 2018, Vol.27 (8), p.256-262

2018

Volltextzugriff (PDF)

First‐in‐human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy

Allergy (Copenhagen), 2022-10, Vol.77 (10), p.3096-3107

2022

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(63)

Sprache

Englisch
(63)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations

Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1

Alum impairs tolerogenic properties induced by allergoid‐mannan conjugates inhibiting mTOR and metabolic reprogramming in human DCs

Trained immunity induction by the inactivated mucosal vaccine MV130 protects against experimental viral respiratory infections

Grass pollen allergoids conjugated with mannan for subcutaneous and sublingual immunotherapy: a dose-finding study

A pilot study of immunotherapy in dogs with atopic dermatitis using a mannan‐Dermatophagoides farinae allergoid targeting dendritic cells

The Universal Dynamics of Tumor Growth

Candida albicans V132 induces trained immunity and enhances the responses triggered by the polybacterial vaccine MV140 for genitourinary tract infections

A Combination of Polybacterial MV140 and Candida albicans V132 as a Potential Novel Trained Immunity-Based Vaccine for Genitourinary Tract Infections

State of the Art in CAR-T Cell Therapy for Solid Tumors: Is There a Sweeter Future?

MV130 in the Prevention of Recurrent Respiratory Tract Infections: A Retrospective Real-World Study in Children and Adults

MV140 Mucosal Vaccine Induces Targeted Immune Response for Enhanced Clearance of Uropathogenic E. coli in Experimental Urinary Tract Infection

Skin Testing With Peach Peel Extract Versus Serum IgE to Pru p 3 as a Stronger Predictor of Peach-Induced Anaphylaxis

Extending the clinical horizons of mucosal bacterial vaccines: current evidence and future prospects

Influence of environmental drivers on allergy to pollen grains in a case study in Spain (Madrid): meteorological factors, pollutants, and airborne concentration of aeroallergens

Human Oral Epithelial Cells Impair Bacteria-Mediated Maturation of Dendritic Cells and Render T Cells Unresponsive to Stimulation

Allergoid–mannan conjugates reprogram monocytes into tolerogenic dendritic cells via epigenetic and metabolic rewiring

Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Children: A Randomized, Double-Blind, Placebo-controlled Clinical Trial

Subjects develop tolerance to Pru p 3 but respiratory allergy to Pru p 9: A large study group from a peach exposed population

Do bacterial vaccines/adjuvants prevent wheezing episodes in children?

A randomized, double‐blind, placebo‐controlled trial with mannan‐conjugated birch pollen allergoids

Allergoid‐mannan conjugates imprint tolerogenic features in human macrophages

From trained immunity in allergy to trained immunity‐based allergen vaccines

Novel vaccines targeting dendritic cells by coupling allergoids to mannan

First‐in‐human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy

Suchergebnisse filtern